CytoMed Therapeutics Pte Ltd 新细胞医学 Revenue and Competitors
Employee Data
CytoMed Therapeutics Pte Ltd 新细胞医学's People
| Name | Title | Email/Phone |
|---|
What Is CytoMed Therapeutics Pte Ltd 新细胞医学?
Incorporated in 2018, CytoMed Therapeutics is a spin-off from Singapore’s Agency for Science, Technology and Research ( A*Star) and focuses on translating its patented technologies into gamma delta (γδ) T cell- and natural killer (NK) cell-based “off-the-shelf” immunotherapeutics for a wide range of cancers. We also engage in generating induced pluripotent stem cells (iPSCs) and translating them into “off-the-shelf” cellular therapeutics using our proprietary technologies for our customers.
keywords:N/A
N/A
Total Funding
N/A
Number of Employees
N/A
Revenue (est)
N/A
Employee Growth %
N/A
Valuation
N/A
Accelerator